Institute of Biomedical Research (MRES) Stock Overview
Provides biomedical research and analytical services in Montenegro and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MRES Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Institute of Biomedical Research Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0079 |
| 52 Week High | US$0.028 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 31.67% |
| 3 Month Change | -16.84% |
| 1 Year Change | 88.10% |
| 3 Year Change | -60.10% |
| 5 Year Change | 1,028.57% |
| Change since IPO | -99.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| MRES | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -7.1% | -2.2% | 0.5% |
| 1Y | 88.1% | -4.0% | 20.0% |
Return vs Industry: MRES exceeded the US Life Sciences industry which returned -4% over the past year.
Return vs Market: MRES exceeded the US Market which returned 20% over the past year.
Price Volatility
| MRES volatility | |
|---|---|
| MRES Average Weekly Movement | 30.6% |
| Life Sciences Industry Average Movement | 8.7% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MRES's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MRES's weekly volatility (31%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Drasko Pekovic | mrescorp.com |
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators.
Institute of Biomedical Research Corp. Fundamentals Summary
| MRES fundamental statistics | |
|---|---|
| Market cap | US$18.95m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
Is MRES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRES income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MRES perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/02 01:59 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Institute of Biomedical Research Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.